Doctronic
Coverage of Doctronic in the Nexus archive.
- Is AI ready to take over your prescriptions? Some doctors are wary
A Utah-based AI prescription refill program using the chatbot Doctronic has sparked debate over AI's role in medicine, with doctors and experts raising concerns about regulation, safety, and the legal framework for non-human medical decision-making. The program operates under a state regulatory sandbox but faces opposition from medical licensing boards due to risks like drug interactions.
- Is AI ready to take over your prescriptions? Doctors are wary of Utah's automated refill program
A Utah-based AI prescription refill program using chatbot Doctronic has sparked debate over AI's role in medicine, with doctors and experts raising concerns about regulation, safety, and legal oversight. The program, operating under a state regulatory sandbox, initially involved human review of AI-generated refills but plans to transition to full automation, prompting criticism from medical licensing boards.
- Opinion: AI doctors should be licensed. Here’s a framework to do that
Utah's Medical Licensing Board called for the suspension of a pilot program with Doctronic, an AI company that evaluates patients and recommends prescription renewals. The board warned that proceeding without clinical oversight could put citizens at risk. The program was launched without the board's knowledge.